BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27245352)

  • 21. Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells.
    Yabut O; Domogauer J; D'Arcangelo G
    J Neurosci; 2010 Mar; 30(11):4004-14. PubMed ID: 20237271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cell-cycle negative regulatory gene ANA is over-expressed in the brain tissues of patients with Down syndrome].
    He XJ; Zhang Q; Ma LP; Yang LJ; Shen H; Guo JZ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):608-11. PubMed ID: 16378112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global DNA hypermethylation in down syndrome placenta.
    Jin S; Lee YK; Lim YC; Zheng Z; Lin XM; Ng DP; Holbrook JD; Law HY; Kwek KY; Yeo GS; Ding C
    PLoS Genet; 2013 Jun; 9(6):e1003515. PubMed ID: 23754950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development.
    Hämmerle B; Elizalde C; Tejedor FJ
    Eur J Neurosci; 2008 Mar; 27(5):1061-74. PubMed ID: 18364031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dyrk1A influences neuronal morphogenesis through regulation of cytoskeletal dynamics in mammalian cortical neurons.
    Martinez de Lagran M; Benavides-Piccione R; Ballesteros-Yañez I; Calvo M; Morales M; Fillat C; Defelipe J; Ramakers GJ; Dierssen M
    Cereb Cortex; 2012 Dec; 22(12):2867-77. PubMed ID: 22215728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Widespread domain-like perturbations of DNA methylation in whole blood of Down syndrome neonates.
    Henneman P; Bouman A; Mul A; Knegt L; van der Kevie-Kersemaekers AM; Zwaveling-Soonawala N; Meijers-Heijboer HEJ; van Trotsenburg ASP; Mannens MM
    PLoS One; 2018; 13(3):e0194938. PubMed ID: 29601581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome.
    Old RW; Crea F; Puszyk W; Hultén MA
    Reprod Biomed Online; 2007 Aug; 15(2):227-35. PubMed ID: 17697502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developmental epigenetic modification regulates stochastic expression of clustered protocadherin genes, generating single neuron diversity.
    Toyoda S; Kawaguchi M; Kobayashi T; Tarusawa E; Toyama T; Okano M; Oda M; Nakauchi H; Yoshimura Y; Sanbo M; Hirabayashi M; Hirayama T; Hirabayashi T; Yagi T
    Neuron; 2014 Apr; 82(1):94-108. PubMed ID: 24698270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trans-acting epigenetic effects of chromosomal aneuploidies: lessons from Down syndrome and mouse models.
    Do C; Xing Z; Yu YE; Tycko B
    Epigenomics; 2017 Feb; 9(2):189-207. PubMed ID: 27911079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of DYRK1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome.
    Hijazi M; Fillat C; Medina JM; Velasco A
    Exp Neurol; 2013 Jan; 239():229-34. PubMed ID: 23124096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A repressor complex, AP4 transcription factor and geminin, negatively regulates expression of target genes in nonneuronal cells.
    Kim MY; Jeong BC; Lee JH; Kee HJ; Kook H; Kim NS; Kim YH; Kim JK; Ahn KY; Kim KK
    Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13074-9. PubMed ID: 16924111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neprilysin Is Suppressed by Dual-Specificity Tyrosine-Phosphorylation Regulated Kinase 1A (DYRK1A) in Down-Syndrome-Derived Fibroblasts.
    Kawakubo T; Mori R; Shirotani K; Iwata N; Asai M
    Biol Pharm Bull; 2017; 40(3):327-333. PubMed ID: 28250274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agglomerative epigenetic aberrations are a common event in human breast cancer.
    Novak P; Jensen T; Oshiro MM; Watts GS; Kim CJ; Futscher BW
    Cancer Res; 2008 Oct; 68(20):8616-25. PubMed ID: 18922938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide profiling of DNA methylation reveals preferred sequences of DNMTs in hepatocellular carcinoma cells.
    Fan H; Zhao Z; Cheng Y; Cui H; Qiao F; Wang L; Hu J; Wu H; Song W
    Tumour Biol; 2016 Jan; 37(1):877-85. PubMed ID: 26254611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice.
    Nakano-Kobayashi A; Awaya T; Kii I; Sumida Y; Okuno Y; Yoshida S; Sumida T; Inoue H; Hosoya T; Hagiwara M
    Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10268-10273. PubMed ID: 28874550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells.
    Zhao J; Liang Q; Cheung KF; Kang W; Lung RW; Tong JH; To KF; Sung JJ; Yu J
    Cancer; 2013 Jan; 119(2):304-12. PubMed ID: 22833454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adaptation of the targeted capture Methyl-Seq platform for the mouse genome identifies novel tissue-specific DNA methylation patterns of genes involved in neurodevelopment.
    Hing B; Ramos E; Braun P; McKane M; Jancic D; Tamashiro KL; Lee RS; Michaelson JJ; Druley TE; Potash JB
    Epigenetics; 2015; 10(7):581-96. PubMed ID: 25985232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated analysis of DNA methylation and RNA‑sequencing data in Down syndrome.
    Zhang J; Zhou W; Liu Y; Li N
    Mol Med Rep; 2016 Nov; 14(5):4309-4314. PubMed ID: 27667480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNMT3L promotes neural differentiation by enhancing STAT1 and STAT3 phosphorylation independent of DNA methylation.
    Qin L; Qiao C; Sheen V; Wang Y; Lu J
    Prog Neurobiol; 2021 Jun; 201():102028. PubMed ID: 33636226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of improved human cerebral organoids from single copy DYRK1A knockout induced pluripotent stem cells in trisomy 21: hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome.
    Çağlayan ES
    Cell Biol Int; 2016 Dec; 40(12):1256-1270. PubMed ID: 27743462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.